These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2542665)

  • 1. [Efficacy of live varicella vaccine strain (Oka) in high-risk patients].
    Eizuru Y; Minamishima Y
    Nihon Rinsho; 1989 Feb; 47(2):424-8. PubMed ID: 2542665
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of live attenuated Varicella vaccine in high risk susceptibles--a preliminary report.
    Gershon AA; Steinberg S; Borkowsky W
    Dev Biol Stand; 1982; 52():391-7. PubMed ID: 6299849
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
    Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus. Prospects for active immunization.
    Gershon AA
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):170-4. PubMed ID: 210654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccine against varicella-zoster].
    Nicodemo AC; Nicodemo EL; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):55-8. PubMed ID: 2831610
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoster vaccine: current status and future prospects.
    Oxman MN
    Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward.
    Asano Y; Nakayama H; Yazaki T; Ito S; Isomura S
    Pediatrics; 1977 Jan; 59(1):8-12. PubMed ID: 190584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylaxis and treatment of alpha herpesvirus infection--vaccine].
    Kimura H
    Nihon Rinsho; 2000 Apr; 58(4):928-32. PubMed ID: 10774218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of varicella vaccine.
    Plotkin SA; Arbetter AA; Starr SE
    Postgrad Med J; 1985; 61 Suppl 4():155-62. PubMed ID: 3014474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases.
    Konno T; Yamaguchi Y; Minegishi M; Goto Y; Tsuchiya S
    Biken J; 1984 Sep; 27(2-3):73-5. PubMed ID: 6100062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A live varicella vaccine (Oka strain). Papers presented at the International Workshop on Live Varicella Vaccine. Osaka, Japan, November 14, 1983.
    Biken J; 1984 Sep; 27(2-3):31-141. PubMed ID: 6100053
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
    Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR
    J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
    N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus vaccine--grown-ups need it, too.
    Gilden DH
    N Engl J Med; 2005 Jun; 352(22):2344-6. PubMed ID: 15930426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.